Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Share-based Compensation (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Share-based Compensation data on record, last reported at $2.7 million in Q4 2025.

  • For Q4 2025, Share-based Compensation fell 4.4% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $10.9 million, down 10.12%, while the annual FY2025 figure was $11.2 million, 20.36% down from the prior year.
  • Share-based Compensation reached $2.7 million in Q4 2025 per PBH's latest filing, up from $1.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.1 million in Q2 2023 and bottomed at $1.7 million in Q1 2022.
  • Average Share-based Compensation over 5 years is $2.9 million, with a median of $2.7 million recorded in 2025.
  • Peak YoY movement for Share-based Compensation: soared 105.38% in 2022, then plummeted 42.14% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $2.2 million in 2021, then rose by 8.91% to $2.4 million in 2022, then rose by 0.66% to $2.4 million in 2023, then increased by 16.99% to $2.9 million in 2024, then dropped by 4.4% to $2.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $2.7 million in Q4 2025, $1.8 million in Q3 2025, and $3.7 million in Q2 2025.